Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matria Healthcare (MATR) -- Ignore unavailable to you. Want to Upgrade?

To: GREATMOOD who wrote (153)	8/12/1998 2:57:00 AM
From: W Shakespeare	Read Replies (1) \| Respond to of 220

Insider buying by three officers of Matria Healthcare: biz.yahoo.com Matria's insider buying appeared in the Wall Street Journal's table of net changes in insider activity. Management is apparently confident of its ability to expand its disease management programs.

To: GREATMOOD who wrote (153)	10/6/1998 11:35:00 AM
From: W Shakespeare	Read Replies (1) \| Respond to of 220

Matria Healthcare Announces Write-Down Of Intangibles And Comments OnExpected Financial Results MARIETTA, Ga., Oct. 6 /PRNewswire/ -- Matria Healthcare, Inc. (Nasdaq: MATR) announced today it expects to record a charge in the third quarter ranging between $90 to $95 million for the write-down of goodwill and other intangible assets that resulted from the 1996 merger of Tokos Medical Corporation and Healthdyne Maternity Management. The charge is based on the Company's determination that these intangible assets have diminished future value. Donald R. Millard, President and Chief Executive Officer, commented, "We have aggressively pursued our strategy of diversification and, during the third quarter, our disease management services were expanded beyond maternity management into the broader market of women's health as well as into the cardiology, respiratory disorders, and general diabetes markets. Diversification into these high-growth disease management markets is the foundation for a substantial portion of Matria's expected growth. As a result of the charge, the reporting of our future financial results will be more reflective of the progress of our diversified Company." The Company also announced its reduced revenues and earnings expectations for the third quarter 1998 and annual 1998 and 1999. The Company anticipates revenues for the third quarter 1998 to be approximately $34 million, 1.5% above second quarter 1998, and 7.7% lower than revenues for the third quarter 1997. Matria expects third quarter 1998 earnings, excluding amortization of goodwill and other intangibles, to be in the range of $2.5 million, or $0.06 per share. The Company expects 1998 annual revenues of approximately $136 million and earnings, before goodwill and other intangibles amortization, ranging from $11 million to $13 million, or $0.30 to $0.35 per share. The Company also announced preliminary expectations for 1999 operating earnings and earnings per share, before amortization of goodwill and other intangibles, to grow at a rate of 40% to 50% in excess of the comparable 1998 numbers on revenue growth of approximately 15%. Management commented that the revenue shortfall is primarily a result of decreased physician prescriptions for the Company's preterm labor management services. Earnings for the quarter were also affected by costs associated with the Company's accelerated move into a broadened disease management strategy. Millard further commented, "Despite the downturn in revenues, we are encouraged by the growth in our diabetes business, up 74% in revenues over the 1998 second quarter, and the progress of our recent acquisition of Quality Diagnostic Services, Inc., which continues to set monthly records in patient census, revenues and profits. We have also expanded our managed care sales efforts and infrastructure to accommodate our rapid movement into the cardiology, respiratory disorders, and general diabetes markets. As a result of these initiatives, Matria is well-positioned to respond to the increased market demand at a faster than expected pace." This press release contains forward-looking statements that involve risks and uncertainties, including developments in the healthcare industry, third- party actions over which the Company does not have control, and regulatory requirements applicable to the Company's business, as well as other risks detailed from time to time in the Company's reports filed with the Securities and Exchange Commission. Matria Healthcare, Inc. is the leading provider of comprehensive disease management services for health plans and employers for women's health and the chronic conditions of diabetes, respiratory disorders, and cardiovascular disease. SOURCE Matria Healthcare, Inc. CO: Matria Healthcare, Inc. ST: Georgia IN: HEA SU: ERP 10/06/98 07:31 EDT prnewswire.com